Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | THRB | P10828 | 1/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.59 |
| ▸ | BIRC2 | Q13490 | 1/20 | 0.59 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | REN | P00797 | 1/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24628029 | 0.95 | BIRC2 (0.62) | ALDH1A1THRBCYP2C9CYP2C19HSD17B10 | |
| SCHEMBL5493329 | 0.89 | ALDH1A1 (0.72) | ALDH1A1THRBCYP2C9CYP2C19HSD17B10 | |
| SCHEMBL27336415 | 0.89 | ALDH1A1 (0.72) | ALDH1A1THRBCYP2C9CYP2C19HSD17B10 | |
| SCHEMBL24346312 | 0.89 | ALDH1A1 (0.72) | ALDH1A1THRBCYP2C9CYP2C19HSD17B10 | |
| Hydrochloric Acid SCHEMBL27509764 | 0.88 | ALDH1A1 (0.71) | ALDH1A1THRBCYP2C9CYP2C19HSD17B10 | |
| Hydrochloric Acid SCHEMBL5966929 | 0.88 | ALDH1A1 (0.71) | ALDH1A1THRBCYP2C9CYP2C19HSD17B10 | |
| SCHEMBL29498151 | 0.87 | BIRC2 (0.62) | ALDH1A1THRBCYP2C9CYP2C19HSD17B10 | |
| SCHEMBL30055789 | 0.85 | SSTR3 (0.61) | ALDH1A1THRBCYP2C9CYP2C19HSD17B10 | |
| SCHEMBL30834825 | 0.84 | ALDH1A1 (0.63) | ALDH1A1THRBCYP2C9CYP2C19HSD17B10 | |
| SCHEMBL10867497 | 0.84 | ALDH1A1 (0.63) | ALDH1A1THRBCYP2C9CYP2C19HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022149584-A1 | PEPTIDE | ＡＧＣ株式会社 | 2022-07-14 | — | — | WO | disclosed |
| EP-3995486-A1 | PEPTIDE AND METHOD FOR MANUFACTURING SAME | AGC INC. (JP) | 2022-05-11 | — | — | EP | disclosed |
| US-20220119440-A1 | PEPTIDE AND METHOD FOR MANUFACTURING SAME | AGC Inc. (JP) | 2022-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220119440-A1 | PEPTIDE AND METHOD FOR MANUFACTURING SAME | VIP, RFC2, QRFPR | ALDH1A1 4069/4885THRB 2326/4885CYP2C9 2236/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.